US Patent 7291333 Blockade of protein C activation reduces microvascular surgical blood loss

Patent 7291333 was granted and assigned to Oklahoma Medical Research Foundation on November, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Oklahoma Medical Research Foundation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

72913330

Patent Inventor Names

Philip C. Comp0

Date of Patent

November 6, 2007

Patent Application Number

083230600

Date Filed

October 14, 1994

Patent Primary Examiner

‌

Ronald B. Schwadron

Patent abstract

A method of inhibiting microvascular bleeding is provided. Antibody to protein C administered to a patient in a pharmaceutically acceptable carrier prevents anticoagulation by greater than 90% of activated protein C in human plasma.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7291333 Blockade of protein C activation reduces microvascular surgical blood loss

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API